Literature DB >> 817789

M components-a review of 1242 cases.

A Ameis, H S Ko, W Pruzanski.   

Abstract

Among 1242 patients referred for immunologic investigation 1255 M components were detected in the serum. Of these patients 50.9% had multiple myeloma, 18.1% had nonmyelomatous malignant diseases such as macroglobulinemia, lymphoma, leukemia or cancer, 4.3% had connective tissue diseases, 2.5% had primary generalized amyloidosis (PGA) and the rest had various "benign" conditions. Whereas IgG was the commonest M component in multiple myeloma, connective tissue diseases and the other benign conditions, IgM was the commonest M component in lymphoma and leukemia; Bence Jones proteinemia was most frequently observed in PGA. The ratio of kappa to lambda light chains varied from 1.7:1 in IgG myeloma to 1:9 in IgD myeloma, and was 1:2.1 in PGA. Bence Jones protein was detected in 422 (66%) of 640 urine samples tested, the prevalence ranging from more than 70% in multiple myeloma and PGA to as low as 36% in various benign conditions. It is evident that the class and type of M components and the presence of Bence Jones proteinuria have no definite significance with regard to the diagnosis. Therefore, thorough investigation and follow-up at regular intervals are required when M components are detected.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 817789      PMCID: PMC1957075     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  8 in total

1.  Transient human monoclonal immunoglobulins.

Authors:  F Danon; M Seligmann
Journal:  Scand J Immunol       Date:  1972       Impact factor: 3.487

2.  Frequency of pathological proteins (M-components) om 6,995 sera from an adult population.

Authors:  U Axelsson; R Bachmann; J Hällén
Journal:  Acta Med Scand       Date:  1966-02

Review 3.  Disturbances of the immunoglobulins.

Authors:  J R Hobbs
Journal:  Sci Basis Med Annu Rev       Date:  1966

4.  Frequency of monoclonal gammapathy ('M components') in 13,400 sera from blood donors.

Authors:  J M Fine; P Lambin; P Leroux
Journal:  Vox Sang       Date:  1972       Impact factor: 2.144

5.  M-components in immunoproliferative disorders. Electrophoretic and immunologic analysis of 200 cases.

Authors:  Z A Zawadzki; G A Edwards
Journal:  Am J Clin Pathol       Date:  1967-10       Impact factor: 2.493

6.  [The distribution of paraproteinaemias according to the sex and age of patients; classes, subclasses and light chain types of paraproteins (author's transl)].

Authors:  A Oberdorfer; K Schnauffer; H J Lange; A Neiss
Journal:  Z Klin Chem Klin Biochem       Date:  1973-02

7.  Pathologic conditions associated with plasma cell dyscrasias: a study of 806 cases.

Authors:  T Isobe; E F Osserman
Journal:  Ann N Y Acad Sci       Date:  1971-12-31       Impact factor: 5.691

8.  Heterogeneity of IgM/IgG cryocomplexes: immunological-clinical correlation.

Authors:  H L MacKechnie; M A Ogryzlo; W Pruzanski
Journal:  J Rheumatol       Date:  1975-06       Impact factor: 4.666

  8 in total
  11 in total

1.  Multiple myeloma.

Authors:  R M Meyer
Journal:  Can Fam Physician       Date:  1985-06       Impact factor: 3.275

2.  Establishment of a novel B cell clonality analysis using single-strand conformation polymorphism of immunoglobulin light chain messenger signals.

Authors:  S Shiokawa; J Nishimura; K Ohshima; N Uike; K Yamamoto
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

3.  An overview of monoclonal gammapathies.

Authors:  T Malati
Journal:  Indian J Clin Biochem       Date:  2001-01

4.  Survey of monoclonal gammopathy in western France: incidence and unexpected high frequency of IgM.

Authors:  D Hurez; P Youinou; J Gombert; J L Preud'Homme
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

5.  Paraproteinaemia in neurological disease: incidence, associations, and classification of monoclonal immunoglobulins.

Authors:  S N Kahn; P G Riches; J Kohn
Journal:  J Clin Pathol       Date:  1980-07       Impact factor: 3.411

Review 6.  Prevalence, clinical aspects, and natural history of IgM MGUS.

Authors:  Mary L McMaster; Ola Landgren
Journal:  Cytometry B Clin Cytom       Date:  2010       Impact factor: 3.058

7.  Neuropathy, amyloidosis, and monoclonal gammopathy.

Authors:  J W Fitting; A Bischoff; F Regli; G De Crousaz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-03       Impact factor: 10.154

8.  Changing biclonal gammopathy due to different lymphocyte clones in acquired immunodeficiency syndrome with Kaposi's sarcoma.

Authors:  H Piechowiak; R Hehlmann; J Abb; V Erfle; F D Goebel; M M Kochen; G Kreeb
Journal:  Klin Wochenschr       Date:  1985-10-15

9.  Double staining immunofluorescence procedure for enumeration of cells containing cytoplasmic immunoglobulin in human bone marrow: 40 selected cases.

Authors:  M J Ayliffe
Journal:  J Clin Pathol       Date:  1985-09       Impact factor: 3.411

10.  Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes: the POEMS syndrome.

Authors:  R E Solomons; D D Gibbs
Journal:  J R Soc Med       Date:  1982-07       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.